|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating activities | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
| Net realized (gain) loss | |||
| Change in net unrealized (appreciation) depreciation of investments | |||
| Net amortization of investment discounts and premiums | |||
| Interest and dividend income paid in kind | |||
| Amortization of deferred debt issuance costs | |||
| Changes in assets and liabilities: | |||
| Purchases of investments | |||
| Proceeds from disposition of investments | |||
| Decrease (increase) in interest, dividends and fees receivable | |||
| Decrease (increase) in receivable for investments sold | |||
| Decrease (increase) in prepaid expenses and other assets | |||
| Increase (decrease) in interest and debt related payables | |||
| Increase (decrease) in incentive fees payable | |||
| Increase (decrease) in management fees payable | |||
| Increase (decrease) in accrued capital gains incentive fees | |||
| Increase (decrease) in reimbursements due to the Investment Adviser | |||
| Increase (decrease) in payable for investments purchased | |||
| Increase (decrease) in accrued expenses and other liabilities | |||
| Net cash provided by (used in) operating activities | |||
| Financing activities | |||
| Proceeds from common shares sold | |||
| Contribution received in advance | |||
| Proceeds from issuance of Notes | |||
| Draws on credit facilities | |||
| Repayments of credit facility draws | |||
| Payments of debt issuance costs | |||
| Dividends paid in cash to shareholders | |||
| Payments of repurchased shares | |||
| Net cash provided by (used in) financing activities | |||
| Net increase (decrease) in cash and cash equivalents (including restricted cash) | |||
| Cash and cash equivalents (including restricted cash) at beginning of period | |||
| Cash and cash equivalents (including restricted cash) at end of period | |||
| Supplemental cash flow information | |||
| Interest payments | |||
| Excise tax payments | |||
| Distribution payable | |||
| Reinvestment of dividends during the period |
Loading...